Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases

Overview

The intended pilot project aims at evaluating the feasibility and acceptability of questionnaires about resilience and quality of life in two different patient groups (either with a gynaecological carcinoma ora chronic gynaecological disease). The results provided by this pilot study will build the basis of an upcoming, larger project including these questionnaires and the main objective of assessing resilience. More precisely, the study aims at answering the following questions. How is the overall resilience and quality of life in the target population at one assessment point? Are the instruments used in this pilot feasible for the target population when assessing resilience and quality of life?

Full Title of Study: “Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases: A Pilot Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 26, 2019

Interventions

  • Other: Connor Davidson Resilience Scale (CD-RISC 10)
    • questionnaires about resilience (Connor Davidson Resilience Scale(CD-RISC 10)) and quality of life (EQ-5D-5L)

Arms, Groups and Cohorts

  • gynecological cancer
    • all patients having a consultation doctor during the recruiting time
  • chronic gynecological disease
    • all patients having a consultation doctor during the recruiting time

Clinical Trial Outcome Measures

Primary Measures

  • resilience measured by questionnaire
    • Time Frame: up to 1 year
    • Total Score of the resilience questions is 0 to 40, 10 subscales from 0 to 4 (summed up for total score), the higher the score the better the resilience

Secondary Measures

  • quality of life measured by questionnaire
    • Time Frame: up to 1 year
    • Questions about Quality of life: Total score 0-25, 5 subscales 0 to 5 (summed up for total score), the higher the score the lower is Quality of life.

Participating in This Clinical Trial

Inclusion Criteria

  • female, – >18 years old, – german speaking exclusion criteria:

  • insufficient study language skills

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Basel, Switzerland
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Viola Heinzelmann-Schwarz, Prof. Dr. MD, Principal Investigator, University Hospital, Basel, Switzerland

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.